A Phase I/II Study of Combination Immunotherapy for Advanced Cancers Including HPV-Associated Malignancies, Small Bowel, and Colon Cancers
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Instituto do Cancer do Estado de São Paulo
Shanghai Bovax Biotechnology Co., Ltd.